Literature DB >> 7576918

Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop.

J L Sankalé1, R S de la Tour, B Renjifo, T Siby, S Mboup, R G Marlink, M E Essex, P J Kanki.   

Abstract

Studies of HIV-2 infection have shown lower rates of sexual and perinatal transmission and a prolonged incubation period to AIDS as compared to HIV-1. To evaluate the role of genetic variation in HIV pathogenesis, we studied intrapatient variability in the V3 loop of the HIV-2 envelope gene over time in five seropositive individuals. Proviral sequences derived from uncultured PBMC DNA (n = 102) demonstrated an average sequence heterogeneity within a sample of 1.4% (0-4.1%). This was significantly lower than the V3 sequence heterogeneity observed in HIV-1, which can be as high as 6.1%. In HIV-2-seropositive healthy patients the average intrapatient nucleotide variability rate was 0.6% compared to 2.0% in patients with clinical AIDS. The lower rate of variability between HIV-2 and HIV-1 is compatible with differences in transmission and pathogenesis of these two related viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576918     DOI: 10.1089/aid.1995.11.617

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Molecular investigation of human immunodeficiency virus type 2 subtype a cases in South Korea.

Authors:  Jeong-Gu Nam; Gab Jung Kim; Jin Young Baek; Soon Duck Suh; Mee Kyung Kee; Joo-Shil Lee; Sung Soon Kim
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Authors:  N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.

Authors:  C Moog; H J Fleury; I Pellegrin; A Kirn; A M Aubertin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Authors:  Joakim Esbjörnsson; Patrik Medstrand; Angelica A Palm; Philippe Lemey; Marianne Jansson; Fredrik Månsson; Anders Kvist; Zsófia Szojka; Antonio Biague; Zacarias José da Silva; Sarah L Rowland-Jones; Hans Norrgren
Journal:  mBio       Date:  2019-01-08       Impact factor: 7.867

5.  The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Authors:  Pedro Borrego; José Maria Marcelino; Cheila Rocha; Manuela Doroana; Francisco Antunes; Fernando Maltez; Perpétua Gomes; Carlos Novo; Helena Barroso; Nuno Taveira
Journal:  Retrovirology       Date:  2008-09-08       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.